Long-term outcomes of antifibrotic treatments in patients with idiopathic pulmonary fibrosis: Real-world experience

被引：0
|
作者：
Nayci, Sibel [1 ]
Polat, Demet [1 ]
Ozgur, Eylem Sercan [1 ]
Ozge, Cengiz [1 ]
机构：
[1] Mersin Univ, Mersin, Turkey
来源：
EUROPEAN RESPIRATORY JOURNAL | 2020年 / 56卷
关键词：
Idiopathic pulmonary fibrosis; Spirometry; Treatments;
D O I：
10.1183/13993003.congress-2020.1845
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
1845
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Long-term, real-world experience of pasireotide dose reduction in patients with acromegaly
    Marques, Nelma Veronica
    Wildemberg, Luiz Eduardo Armondi
    Gadelha, Monica R.
    [J]. ENDOCRINE CONNECTIONS, 2023, 12 (10)
  • [42] Treatments And Outcomes Of Idiopathic Pulmonary Fibrosis In A Medicare Population Prior To Approval Of Antifibrotic Therapies
    Mooney, J.
    Chang, E.
    Lalla, D.
    Papoyan, E.
    Raimundo, K.
    Reddy, S. R.
    Stauffer, J. L.
    Yan, J. T.
    Broder, M. S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [43] Diagnostic and treatment standards in idiopathic pulmonary fibrosis in the era of antifibrotic drugs in Poland: A real-world practice survey
    Majewski, Sebastian
    Lewandowska, Katarzyna
    Martusewicz-Boros, Magdalena Maria
    Piotrowski, Wojciech Jerzy
    [J]. ADVANCES IN RESPIRATORY MEDICINE, 2019, 87 (06) : 221 - 230
  • [44] Clinical Experience of the Long-term Use of Pirfenidone for Idiopathic Pulmonary Fibrosis
    Bando, Masashi
    Yamauchi, Hiroyoshi
    Ogura, Takashi
    Taniguchi, Hiroyuki
    Watanabe, Kentaro
    Azuma, Arata
    Homma, Sakae
    Sugiyama, Yukihiko
    [J]. INTERNAL MEDICINE, 2016, 55 (05) : 443 - 448
  • [45] Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications
    Bryan T. Kelly
    Viengneesee Thao
    Timothy M. Dempsey
    Lindsey R. Sangaralingham
    Stephanie R. Payne
    Taylor T. Teague
    Teng Moua
    Nilay D. Shah
    Andrew H. Limper
    [J]. BMC Pulmonary Medicine, 21
  • [46] Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications
    Kelly, Bryan T.
    Thao, Viengneesee
    Dempsey, Timothy M.
    Sangaralingham, Lindsey R.
    Payne, Stephanie R.
    Teague, Taylor T.
    Moua, Teng
    Shah, Nilay D.
    Limper, Andrew H.
    [J]. BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [47] Fractional Flow Reserve and Long-Term Outcomes in Consecutive 'Real-World' Patients
    Kelly, Damian J.
    Liang, Michael L.
    Puri, Aniket
    Perera, Suresh
    Menon, Madhav
    Devlin, Gerard
    [J]. CIRCULATION, 2010, 122 (21)
  • [48] Nintedanib in the management of idiopathic pulmonary fibrosis: clinical trial evidence and real-world experience
    Rivera-Ortega, Pilar
    Hayton, Conal
    Blaikley, John
    Leonard, Colm
    Chaudhuri, Nazia
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2018, 12
  • [49] Real-world cohort evaluation of the impact of the antifibrotics in patients with idiopathic pulmonary fibrosis
    Dempsey, Timothy M.
    Thao, Viengneesee
    Helfinstine, David A.
    Chang, Yu-Hui H.
    Sangaralingham, Lindsey
    Limper, Andrew H.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62 (04)
  • [50] Real-world safety profiles of pirfenidone and nintedanib in idiopathic pulmonary fibrosis patients
    Fournier, Dorine
    Jouneau, Stephane
    Bouzille, Guillaume
    Polard, Elisabeth
    Osmont, Marie-Noëlle
    Scailteux, Lucie-Marie
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2022, 76
12345